Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
Pediatric Radiology|January 18, 2012
Contrast-enhanced sonography of malignant pediatric abdominal and pelvic solid tumors: preliminary safety and feasibility dataM Beth McCarville, Sue C Kaste, Fredric A Hoffer, et al.
Journal of Medicinal Chemistry|May 9, 2009
Benzylguanidines and other galegine analogues inducing weight loss in miceGeoffrey D Coxon, Brian L Furman, Alan L Harvey, et al.
Journal of Palliative Medicine|June 28, 2012
Parent-clinician communication intervention during end-of-life decision making for children with incurable cancerPamela S Hinds, Linda L Oakes, Judy Hicks, et al.
Cancer|January 22, 2005
The feasibility of adjuvant interferon alpha-2b in children with high-risk melanomaFariba Navid, Wayne L Furman, Martin Fleming, et al.
Journal of Pediatric Surgery|April 14, 2010
Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experienceJared R Robbins, Matthew J Krasin, Atmaram S Pai Panandiker, et al.
Cancer Immunology, Immunotherapy : CII|September 11, 2020
Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastomaRosa Nguyen, Anand G Patel, Lyra M Griffiths, et al.
Biochimica Et Biophysica Acta|May 24, 2016
Calcineurin proteolysis in astrocytes: Implications for impaired synaptic functionMelanie M Pleiss, Pradoldej Sompol, Susan D Kraner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 12, 2002
Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretionJoseph D Bruton, Raf Lemmens, Chun-Liang Shi, et al.
Pediatric Blood & Cancer|November 15, 2019
Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrineMirko Peitzsch, Elizabeth R Butch, Elizabeth Lovorn, et al.
Journal of Pediatric Surgery|November 6, 2019
Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapyDavid Yanishevski, M Beth McCarville, Mikhail Doubrovin, et al.
Pageof 29